BNP Paribas Financial Markets
CFRX

BNP Paribas Financial Markets’s ContraFect Corporation CFRX Stock Holding History

BNP Paribas Financial Markets’s Portfolio CFRX Stock Details CFRX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q4 		– Sell
-1
Closed -$11 – 5015
2022
Q3 		$11 Buy
+1
New +$50 ﹤0.01% 4708

Other funds holding CFRX

AC
Armistice Capital New York $5.62B AUM 36.06% 1-Year Est. Return
Acadian Asset Management
Acadian Asset Management Boston, Massachusetts $70.5B AUM 36% 1-Year Est. Return
AG
Artal Group Luxembourg $1.01B AUM 29.84% 1-Year Est. Return
FI
Fosun International Hong Kong, China $399M AUM 16.11% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
VF
Virtu Financial New York $2.41B AUM 48.35% 1-Year Est. Return
Two Sigma Investments
Two Sigma Investments New York $124B AUM 33.93% 1-Year Est. Return

BNP Paribas Financial Markets's CFRX Position: Q4 2022 in Review

BNP Paribas Financial Markets sold out of ContraFect Corporation (CFRX) in Q4 2022, closing a stake of 1 share — an estimated $11 sold.

BNP Paribas Financial Markets first reported a position in CFRX in Q3 2022 and held it in 1 quarter. The position peaked at $11 in Q3 2022. 40 funds tracked by Wall St. Rank hold CFRX as of Q4 2022.

  • BNP Paribas Financial Markets reported no remaining ContraFect Corporation position as of Q4 2022 after selling out during the quarter.
  • BNP Paribas Financial Markets sold 1 ContraFect Corporation share in Q4 2022, an estimated $11.
  • BNP Paribas Financial Markets first reported a position in ContraFect Corporation in Q3 2022 and held it in 1 quarter.
  • BNP Paribas Financial Markets's ContraFect Corporation position peaked at $11 in Q3 2022.
  • 40 funds tracked by Wall St. Rank held ContraFect Corporation as of Q4 2022.

Based on BNP Paribas Financial Markets's 13F filing for Q4 2022, filed 14 Feb 2023.